Flash Finance

Citurgia Biochemicals Ltd506373Corporate

Commodity Chemicals Latest results: Mar 2026 13 quarters of data
—
MCap —
Live price not available
Citurgia Biochemicals Ltd — Stock analysis & AI research Citurgia Biochemicals Ltd — Live exchange announcements
AI-assisted data: figures and text on this page are extracted from public quarterly filings with AI assistance, checked automatically and overseen by our editorial team (human in the loop). They may still contain errors or omissions. Verify critical numbers against official company / SEBI / NSE / BSE filings before making any decision. Educational information only, not financial advice.
₹0 Cr
Sales · Mar 2026
₹-0 Cr
Operating Profit · Mar 2026
-233.3% YoY
—
OPM % · Mar 2026
₹-0 Cr
Net Profit · Mar 2026
-116.7% YoY
₹-0.02
EPS · Mar 2026
-100.0% YoY

📝 Citurgia Biochemicals Ltd — results explained

Quarter ended March 2026 (Q4 FY26)

Citurgia Biochemicals Ltd reported revenue of ₹0 crore for the quarter ended March 2026 (Q4 FY26).

The company reported a net loss of ₹0 crore, against a net loss of ₹0 crore in the same quarter last year. Earnings per share (EPS) came in at ₹-0.02.

Full year and trailing twelve months

For the full year FY26, Citurgia Biochemicals Ltd posted revenue of ₹0 crore, with a net loss of ₹1 crore.

On a trailing-twelve-month (TTM) basis, revenue stands at ₹0 crore with a net loss of ₹1 crore.

Shareholding pattern

As of Jun 2026, promoters held 99.36%, public shareholders 0.63% of Citurgia Biochemicals Ltd.

📈 Share price & events

📊 Quarterly trend

₹ crore · OPM % on right axis

🎯 Key metrics

price-linked ratios use the latest close
Valuation
Market Cap ?
N/A
Current Price ?
N/A
P/E ?
N/A
Industry P/E ?
22.50
P/B ?
N/A
P/S ?
N/A
P/FCF ?
N/A
Enterprise Value ?
N/A
EV/EBITDA ?
N/A
PEG ?
N/A
Earnings Yield ?
N/A
Dividend Yield ?
0.00%
Profitability & Returns
Sales (TTM) ?
N/A
OPM ?
N/A
Profit after tax (TTM) ?
₹-1 Cr
EPS (TTM) ?
₹-0.06
ROCE ?
-2,150.0%
ROE ?
9.6%
ROA ?
-7.1%
Growth
Sales — latest qtr ?
₹0 Cr
PAT — latest qtr ?
₹-0 Cr
YoY qtr sales growth ?
N/A
YoY qtr profit growth ?
-116.7%
Sales growth (3y) ?
N/A
Sales growth (5y) ?
N/A
Profit growth (3y) ?
-32%
Profit growth (5y) ?
-5%
Financial Health
Debt ?
₹7 Cr
Debt to Equity ?
-0.89
Interest Coverage ?
N/A
Current Ratio ?
N/A
Ownership
Promoter holding ?
99.36%
Change in promoter holding ?
0.00%
Pledged percentage ?
N/A
Market
Return 3 months ?
N/A
Return 6 months ?
N/A

🗓️ Quarterly results (13 quarters · ₹ Cr)

same fiscal quarter as Mar bestweakest per row · for costs (interest, NPAs) low is best
Metric Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026 YoY % QoQ %
Sales 0000000000000 — —
Operating Profit -0-0-0-0-0-0-0-0-0-0-0-0-0 -233.3% +13.0%
Other Income 0000000000000 — —
Interest 0000000000000 — —
Depreciation 0000000000000 +0.0% +0.0%
Profit Before Tax -0-0-0-0-0-0-0-0-0-0-0-0-0 -116.7% +10.3%
Net Profit -0-0-0-0-0-0-0-0-0-0-0-0-0 -116.7% +10.3%
EPS -0.01-0.01-0.01-0.01-0.01-0.01-0.01-0.01-0.01-0.01-0.01-0.02-0.02 -100.0% +0.0%
OPM % — — — — — — — — — — — — — — —

📆 Annual results (₹ Cr, FY = Apr–Mar)

Metric FY25 FY26 TTM YoY %
Sales ₹0 Cr ₹0 Cr ₹0 Cr —
Operating Profit ₹-0 Cr ₹-1 Cr ₹-1 Cr -121.7%
OPM % — — — —
NPM % — — — —
Other Income ₹0 Cr ₹0 Cr ₹0 Cr —
Depreciation ₹0 Cr ₹0 Cr ₹0 Cr +0.0%
Interest ₹0 Cr ₹0 Cr ₹0 Cr —
EBIT ₹-0 Cr ₹-1 Cr ₹-1 Cr -60.9%
PBT ₹-0 Cr ₹-1 Cr ₹-1 Cr -60.9%
Tax — — — —
Net Profit ₹-0 Cr ₹-1 Cr ₹-1 Cr -64.4%
EPS ₹-0.04 ₹-0.06 ₹-0.06 -50.0%
Material Cost — — — —
Employee Cost — — — —
Extraordinary Items — — — —

🏛️ Balance Sheet (latest 4 periods)

Metric Mar 2023Mar 2024Mar 2025Mar 2026 % Chg
Equity Capital 26.4226.4226.4226.42 +0.0%
Reserves -32.51-32.99-33.41-34.15 -2.2%
Borrowings 6.556.776.836.89 +0.9%
Other Liabilities 10.7310.8410.9211.31 +3.6%
Total Liabilities 11.1911.0410.7610.47 -2.7%
Fixed Assets 1.070.850.620.40 -35.5%
CWIP 0.000.000.000.00 —
Investments 0.000.000.000.00 —
Other Assets 10.1210.1910.1410.07 -0.7%
Total Assets 11.1911.0410.7610.47 -2.7%

💧 Cash Flow (latest 4 periods)

Metric Mar 2023Mar 2024Mar 2025Mar 2026 % Chg
Cash from Operating Activity -0.07-0.14-0.12-0.13 -8.3%
Cash from Investing Activity 0.04-0.050.070.08 +14.3%
Cash from Financing Activity 0.060.220.060.06 +0.0%
Net Cash Flow 0.020.030.010.01 +0.0%
Free Cash Flow -0.07-0.14-0.12-0.13 -8.3%
CFO/OP 33%56%60%25% -58.3%

➗ Ratios (latest 4 periods)

Metric Mar 2022Mar 2023Mar 2024Mar 2025 % Chg
ROCE % -39.61%-68.22%-145.45%-2,150.00% -1378.2%

👥 Shareholding (latest 4 periods)

Metric Sep 2025Dec 2025Mar 2026Jun 2026 % Chg
Promoters 99.36%99.36%99.36%99.36% +0.0%
Public 0.64%0.64%0.63%0.63% +0.0%
No. of Shareholders 5,3835,3835,7675,762 -0.1%

⚖️ Peer comparison

Industry: Commodity Chemicals · top 25 of 50 companies · full page →
# Company CMP MCap (Cr) P/E Sales TTM NP TTM OPM% NPM% Sales YoY% NP YoY% Qtr Rev Δ% Qtr NP Δ%
1 506854 TANFAC Industries ₹2,120.80 6,774 62.7 722 68 15.4% 9.4% 27.6% -20.5% 6.4% -11.3%
2 507753 TGV Sraac ₹89.93 1,096 7.3 1,950 132 17.9% 6.8% 11.5% 41.9% 4.9% 27.3%
3 530477 Vikram Thermo ₹174.50 1,050 12.5 144 44 42.0% 30.4% 7.0% 446.1% 32.4% 67.3%
4 506687 Transpek Industry ₹1,378.50 770 19.7 618 39 14.5% 6.3% -4.4% -6.3% -2.1% -42.7%
5 506808 Tuticorin Alkali ₹84.67 698 30.9 342 33 15.9% 9.8% 9.1% -41.1% 6.0% -31.8%
6 PRIMO Primo Chemicals ₹26.00 630 40.0 560 16 12.3% 2.9% 1.1% 331.6% -1.2% 14.7%
7 539195 POCL Enterprises ₹557.00 414 50.9 1,525 34 4.2% 2.2% -1.3% 23.7% 25.1% -51.0%
8 514440 Blue Pearl ₹46.44 405 — 47 1 2.7% 2.2% 41.5% 62.5% -13.1% 2.6%
9 524634 Alufluoride ₹480.45 396 15.2 192 25 22.1% 12.9% 10.7% 39.7% -39.3% -11.4%
10 500012 Andhra Petrochemicals ₹106.70 373 — 456 -16 -4.5% -3.4% -9.2% 13.5% -44.7% 109.0%
11 544205 National Peroxide ₹1,038.25 344 35.6 319 17 12.1% 5.3% 1.0% 590.7% 44.1% 642.6%
12 500449 Hindustan Organic ₹56.50 239 — 505 -2 0.2% -0.4% 6.9% -103.1% -41.5% 164.0%
13 543993 ARCL Organics ₹73.32 215 5.7 272 10 12.4% 3.8% 8.7% -57.9% -0.6% 128.5%
14 538896 Kanchi Karpooram ₹361.90 161 20.6 155 8 7.4% 4.9% -1.8% -60.9% 16.4% 113.2%
15 524336 Shree Hari ₹73.44 153 3.9 215 12 7.7% 5.5% 30.7% -17.4% 125.8% 455.0%
16 524640 Archit Organosys ₹49.30 139 13.6 145 7 10.8% 5.1% 12.2% 58.7% 11.7% -28.9%
17 524174 Kesar Petroproducts ₹17.79 135 40.4 187 4 8.8% 2.3% 1.1% -2.9% -0.8% -91.3%
18 526231 Standard Surfactants ₹63.44 115 58.7 93 1 1.5% 0.8% -44.1% -3.6% -6.5% 175.0%
19 519097 Ritesh International ₹27.26 80 4.9 182 5 4.9% 2.8% 29.5% 11.2% 44.2% 358.9%
20 506605 Polychem ₹2,750.00 73 3.6 44 30 10.1% 67.9% 5.5% 677.1% 12.7% -216.8%
21 532425 Genus Prime ₹26.28 69 9.1 4 4 85.4% 102.1% 1747.8% 10950.0% 5700.0% 20050.0%
22 524564 Gayatri BioOrganics ₹6.13 63 — — -1 — — — -54.2% — -147.1%
23 506947 Advance Petrochemicals ₹234.65 56 10.3 57 2 8.3% 3.6% -5.1% -93.3% 98.7% 20295.0%
24 526335 Shreyas Interm. ₹10.98 52 — 17 -1 -0.4% -7.5% — 20.4% — 6.7%
25 506373 Citurgia Biochemicals ₹31.64 — — — -1 — — — -64.4% — -116.7%
❓ Frequently asked questions
What was Citurgia Biochemicals Ltd's revenue in Q4 FY26?
Citurgia Biochemicals Ltd reported revenue of ₹0 crore for the quarter ended March 2026 (Q4 FY26).
What was Citurgia Biochemicals Ltd's net profit in Q4 FY26?
The company reported a net loss of ₹0 crore, against a net loss of ₹0 crore in the same quarter last year. Earnings per share (EPS) came in at ₹-0.02.
Who owns Citurgia Biochemicals Ltd? (shareholding pattern)
As of Jun 2026, promoters held 99.36%, public shareholders 0.63% of Citurgia Biochemicals Ltd.
TTM ends 2026-03-31. Amounts are ₹ crore unless stated otherwise. Figures are extracted by AI from public quarterly filings; gaps are filled from public market data. Live price refreshed about twice a day from exchange data. Educational information only — not financial advice.
⚠️ How this site is made: Market data pages are computed automatically from NSE/BSE publications and company filings; news articles and announcement analyses are written with AI assistance, with a human in the loop: our editors review what the AI produces. Both can contain errors. Verify with the original sources before any investment decision. Not investment advice; Flash Finance is not SEBI-registered. How we use AI